These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2140342)

  • 1. Reduction in body weight and cholesterol in spontaneously obese dogs by dehydroepiandrosterone.
    Kurzman ID; MacEwen EG; Haffa AL
    Int J Obes; 1990 Feb; 14(2):95-104. PubMed ID: 2140342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dehydroepiandrosterone combined with a low-fat diet in spontaneously obese dogs: a clinical trial.
    Kurzman ID; Panciera DL; Miller JB; MacEwen EG
    Obes Res; 1998 Jan; 6(1):20-8. PubMed ID: 9526966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA).
    MacEwen EG; Kurzman ID
    J Nutr; 1991 Nov; 121(11 Suppl):S51-5. PubMed ID: 1834816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between analytic values and canine obesity.
    Peña C; Suárez L; Bautista I; Montoya JA; Juste MC
    J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):324-5. PubMed ID: 18477313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of high fat diet and dehydroepiandrosterone (DHEA) administration in the rhesus monkey.
    Christopher-Hennings J; Kurzman ID; Haffa AL; Kemnitz JW; Macewen EG
    In Vivo; 1995; 9(5):415-20. PubMed ID: 8900917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic activity of dirlotapide, a novel microsomal triglyceride transfer protein inhibitor, for weight loss in obese dogs.
    Wren JA; King VL; Campbell SL; Hickman MA
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():33-42. PubMed ID: 17567513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocholesterolemic effect of exogenous dehydroepiandrosterone administration in the rhesus monkey.
    Haffa AL; MacEwen EG; Kurzman ID; Kemnitz JW
    In Vivo; 1994; 8(6):993-7. PubMed ID: 7772752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-obesity effect of two different levels of dehydroepiandrosterone in lean and obese middle-aged female Zucker rats.
    Cleary MP; Zisk JF
    Int J Obes; 1986; 10(3):193-204. PubMed ID: 2944850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety evaluation and treatment affect of LY2190416, a CB-1 antagonist/inverse agonist in growing beagle dogs.
    Nunamaker E; Newhall K; Thompson C; Lucas A; Owens J; Sherman JG
    J Vet Pharmacol Ther; 2011 Dec; 34(6):577-82. PubMed ID: 21323931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon.
    Ngondi JL; Oben JE; Minka SR
    Lipids Health Dis; 2005 May; 4():12. PubMed ID: 15916709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoprotein profile in Japanese obese children.
    Tokunaga K; Ishikawa K; Sudo H; Matsuzawa Y; Yamamoto A; Tarui S
    Int J Obes; 1982; 6(4):399-404. PubMed ID: 6957403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dog obesity: owner attitudes and behaviour.
    Bland IM; Guthrie-Jones A; Taylor RD; Hill J
    Prev Vet Med; 2009 Dec; 92(4):333-40. PubMed ID: 19766333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum butyrylcholinesterase and obesity in dogs: a preliminary report.
    Tvarijonaviciute A; Tecles F; Ceron JJ
    Vet J; 2010 Nov; 186(2):197-200. PubMed ID: 19733105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of cholesterol lipoprotein profile to confirm obesity status in dogs.
    Mori N; Lee P; Kondo K; Kido T; Saito T; Arai T
    Vet Res Commun; 2011 Apr; 35(4):223-35. PubMed ID: 21327518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial.
    Allison DB; Gadbury G; Schwartz LG; Murugesan R; Kraker JL; Heshka S; Fontaine KR; Heymsfield SB
    Eur J Clin Nutr; 2003 Apr; 57(4):514-22. PubMed ID: 12700612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of discontinuing dehydroepiandrosterone supplementation on Zucker rat food intake and hypothalamic neurotransmitters.
    Porter JR; Abadie JM; Wright BE; Browne ES; Svec F
    Int J Obes Relat Metab Disord; 1995 Jul; 19(7):480-8. PubMed ID: 8520638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable effects of weight loss on serum lipids and lipoproteins in obese patients.
    Stevenson DW; Darga LL; Spafford TR; Ahmad N; Lucas CP
    Int J Obes; 1988; 12(6):495-502. PubMed ID: 3235269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cholesterol profiles during treatment of obese outpatients with a very low calorie diet. Effect of initial cholesterol levels.
    Osterman J; Lin T; Nankin HR; Brown KA; Hornung CA
    Int J Obes Relat Metab Disord; 1992 Jan; 16(1):49-58. PubMed ID: 1314244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.